Last reviewed: November 2017
Last updated: November  2017

Important updates

Updated US HPV immunisation schedule for adolescents

  • The US Advisory Committee on Immunization Practices now recommends a 2-dose HPV immunisation schedule for healthy adolescents aged 9 to 14 years. The second dose should be administered 6 to 12 months after the first dose.

  • For those who initiate the vaccination series at ages 15 to 26 years, and for immunocompromised persons, a 3-dose immunisation schedule is still recommended.

??C:topic.page.important.updates.prevention_en_GB??

Original source of update

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • female aged 19-22
  • male aged 22-26
  • sessile exophytic papillomas

Other diagnostic factors

  • asymptomatic
  • pruritus
  • bleeding
  • pain
  • urinary symptoms

Risk factors

  • intercourse at an early age
  • increasing number of lifetime sexual partners
  • increasing number of partner's sexual partners
  • immunocompromise

Diagnostic investigations

Treatment algorithm

Contributors

Authors VIEW ALL

Department of Dermatology

University of Texas MD Anderson Cancer Center

Houston

TX

Disclosures

NM declares that she has no competing interests.

Clinical Professor

Departments of Dermatology, Microbiology and Molecular Genetics and Internal Medicine

University of Texas Health Science Center

Houston

TX

Disclosures

SKT declares that he has no competing interests.

Dr Natalia Mendoza and Dr Stephen K. Tyring would like to gratefully acknowledge Dr Brenda L. Pellicane, a previous contributor to this monograph. BLP declares that she has no competing interests.

Peer reviewers VIEW ALL

Clinical Assistant Professor

University of Texas Medical Branch at Galveston

Galveston

TX

Disclosures

AM declares that she has no competing interests.

Consultant Genitourinary Physician

Woolmanhill Hospital

Aberdeen

Scotland

UK

Disclosures

SB declares that he has no competing interests.

Use of this content is subject to our disclaimer